Viehbacher may not be GSK's White Knight

Discussion in 'GlaxoSmithKline' started by Anonymous, Dec 4, 2014 at 10:44 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    If there is any truth to these allegations, Viehbacher may not be as available as he seems:



    "A new lawsuit claims the recently ousted CEO of Sanofi and other executives at the huge drugmaker conducted a scheme in violation of federal law to funnel tens of millions of dollars in kickbacks and other incentives to get the company's diabetes drugs prescribed and sold."


    http://www.cnbc.com/id/102235774?
     

  2. Anonymous

    Anonymous Guest

    Interesting post. If true, CV is yet another executive fraudster among a growing list.
     
  3. Anonymous

    Anonymous Guest

     
  4. Anonymous

    Anonymous Guest

    Disgruntled does not necessarily mean wrong. The 2 guys from GSK who were whistleblowers were disgruntled as well, but they weren't wrong.

    Let the courts decide.
     
  5. Anonymous

    Anonymous Guest

    She also claims about $1 billion is missing! That part should be proved/disproved fairly quickly. This isn't the Pentagon, Sanofi's accountants must have records somewhere.
     
  6. Anonymous

    Anonymous Guest

    We could use the $ 1b
     
  7. Anonymous

    Anonymous Guest

    "White Knight?!" You racist
     
  8. Anonymous

    Anonymous Guest

  9. Anonymous

    Anonymous Guest

    Transparency. Respect for People. Integrity. Patient Focused. Maybe not.
     
  10. Anonymous

    Anonymous Guest

    This guy was hip deep in the fraud at GSK TOO. Just look at the Lauren Stevens trial transcripts and you will know. He belongs in Prison.
     
  11. Anonymous

    Anonymous Guest

    Ultimately he is as responsible for PF as anyone else.
     
  12. Anonymous

    Anonymous Guest

    Just keeps getting better


    Sanofi Is Accused of Using Kickbacks to Encourage Prescribing Diabetes Drugs

    According to the complaint, on October 29, 2014, shares of Sanofi fell $2.85 or almost 6% to close at $45.22 on the news of the termination of Chief Executive Officer, Christopher A. Viehbacher. On December 3, 2014, it was reported by various media outlets that a whistleblower lawsuit had been filed by a former Sanofi paralegal. This suit alleges that Viehbacher, along with other executives, violated federal law by funneling tens of millions of dollars in kickbacks and incentives to get the company's diabetes drugs prescribed and sold. This lawsuit also alleges that Viehbacher was dismissed due to his involvement in the illegal activities, such as kickbacks and incentives, which went on for many years.

    The complaint also alleges that Sanofi: (i) was making improper payments to healthcare professionals in connection with the sale of pharmaceutical products in violation of federal law; (ii) lacked adequate internal controls over financial reporting; and (iii) as a result, the company's public statements were materially false and misleading at all relevant times.
     
  13. Anonymous

    Anonymous Guest

    who cares, go to the Sanofi thread. we have enough problems with our own leadership